non small cell lung cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with L858R mutation 2. Patients with unresectable or relapsing non small cell lung cancer 3. Patients over 20 years old at consent acquisition date 4. Patients receiving afatinib 5. Patients who can provide blood samples 6. Patients who agreed to participate in this study in writing
Exclusion criteria
Exclusion criteria: 1. Patients with interstitial pneumonia 2. Patients with serious complications 3. Patients with a history of serious hypersensitivity 4. Patients who are judged inappropriate to participate in this study by the research director or research contributor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in EGFR mutation allele frequency | — |
Countries
Japan
Contacts
Hamamatsu University School of Medicine Second division, Depertment of Internal Medicine